sulfinpyrazone has been researched along with Atrial Fibrillation in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BAssan, MM | 1 |
| Steele, P | 1 |
| Rainwater, J | 1 |
2 other studies available for sulfinpyrazone and Atrial Fibrillation
| Article | Year |
|---|---|
Sulfinpyrazone, mitral stenosis and atrial fibrillation.
Topics: Atrial Fibrillation; Humans; Mitral Valve Stenosis; Sulfinpyrazone | 1981 |
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
Topics: Atrial Fibrillation; Blood Coagulation; Blood Platelets; Cell Survival; Heart Valve Prosthesis; Huma | 1980 |